Click to Share
 

Medical Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

Premium Press Releases | Show All

13154983
By CorporateAds
Twelve Surgical Centers, Strong Financial Momentum, And A Scalable Growth Strategy Position $CDIX For Its Next Phase Of Expansion
13154972
By CorporateAds
First Commercial Deployment of FDA-Cleared AI-Guided TMS Navigation System, Expanded FDA Pathway for NRX-101, and Growing Commercial Infrastructure Highlight Accelerating Momentum for NRx Pharmaceuticals (N A S D A Q: NRXP)
13153961
By CorporateAds
Strategic Business Transformation, Enterprise Healthcare Expansion, AI-Powered Telehealth Innovation, And Significant Cost Reductions Position $VSEE Health For Potential Multi-Year Growth
13150229
By NaturismRE
The NRE Health Institute has announced the launch of the Non-Sexual Nudity Motivations Study (NSNMS), a new international research initiative examining why people support, oppose, follow, consume, discuss, or participate in non-sexual nudity.
13148761
By Men's Health Network
Men's Health Network (MHN) today officially kicks off Men's Health Month 2026, celebrating the 31st MHM. 2026 MHM begins with unprecedented momentum.
13148676
By CorporateAds
Expanding HOPE Therapeutics Network Positions NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP for Potential Breakout 2026 Growth
13148417
By CorporateAds
NRx Pharmaceuticals, Inc.Improved Financial Position, Commercial Ketamine Manufacturing, FDA Progress, and Expanding Neuroplastic Therapy Infrastructure Position $NRXP for a Potential Breakout Phase
13147059
By CorporateAds
$CDIX Continues Scaling Its Orthopedic, Spine, and Pain Management Footprint as Revenue Growth, Margin Expansion, and Capital Markets Momentum Accelerate
13143773
By CorporateAds
Commercial-Ready Ketamine Production, FDA Alignment, and Expanding AI Neurotherapy Platform Position $NRXP at the Center of a Multi-Billion-Dollar Mental Health Transformation
13140661
By CorporateAds
NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP: Dual FDA Pathways, and an Expanding AI-Driven Treatment Ecosystem Position NRXP at the Forefront of a Multi-Billion-Dollar Mental Health Transformation

All Press Releases

13154983
By CorporateAds
Twelve Surgical Centers, Strong Financial Momentum, And A Scalable Growth Strategy Position $CDIX For Its Next Phase Of Expansion
13154972
By CorporateAds
First Commercial Deployment of FDA-Cleared AI-Guided TMS Navigation System, Expanded FDA Pathway for NRX-101, and Growing Commercial Infrastructure Highlight Accelerating Momentum for NRx Pharmaceuticals (N A S D A Q: NRXP)
13153961
By CorporateAds
Strategic Business Transformation, Enterprise Healthcare Expansion, AI-Powered Telehealth Innovation, And Significant Cost Reductions Position $VSEE Health For Potential Multi-Year Growth
By One Life International LLC
Trusted healthcare coordination for advanced treatments and medical travel support.
13150229
By NaturismRE
The NRE Health Institute has announced the launch of the Non-Sexual Nudity Motivations Study (NSNMS), a new international research initiative examining why people support, oppose, follow, consume, discuss, or participate in non-sexual nudity.
13148761
By Men's Health Network
Men's Health Network (MHN) today officially kicks off Men's Health Month 2026, celebrating the 31st MHM. 2026 MHM begins with unprecedented momentum.
13148676
By CorporateAds
Expanding HOPE Therapeutics Network Positions NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP for Potential Breakout 2026 Growth
13148417
By CorporateAds
NRx Pharmaceuticals, Inc.Improved Financial Position, Commercial Ketamine Manufacturing, FDA Progress, and Expanding Neuroplastic Therapy Infrastructure Position $NRXP for a Potential Breakout Phase
13147059
By CorporateAds
$CDIX Continues Scaling Its Orthopedic, Spine, and Pain Management Footprint as Revenue Growth, Margin Expansion, and Capital Markets Momentum Accelerate
By EyeCool Therapeutics
EyeCool Therapeutics today announced the publication of the first randomized, double‑masked, multicenter clinical trial evaluating its investigational ocular surface cooling device for the treatment of chronic ocular surface pain (COSP) in...
13143773
By CorporateAds
Commercial-Ready Ketamine Production, FDA Alignment, and Expanding AI Neurotherapy Platform Position $NRXP at the Center of a Multi-Billion-Dollar Mental Health Transformation
By GUBERMAN-PMC,LLC
Charleston, Bangkok, Paris, Sofia, Washington DC, and Manila Were Certified Under an Accreditation Identity That Had Already Collapsed Before the Contract Was Signed
13140661
By CorporateAds
NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP: Dual FDA Pathways, and an Expanding AI-Driven Treatment Ecosystem Position NRXP at the Forefront of a Multi-Billion-Dollar Mental Health Transformation
13139611
By CorporateAds
Breakthrough Regulatory Alignment Now Meets Cutting-Edge Robotic Brain Therapy—Positioning $NRXP at the Intersection of Pharma, AI, and National Defense
By VITARIS AIR AMBULANCE PVT LTD
Delivering seamless, life-saving emergency medical transport through ICU-equipped aircraft, train ambulance services, neonatal care systems, and global patient evacuation coordination
13136307
By CorporateAds
NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP Has a One-Day Depression Treatment, AI Monitoring Breakthrough, and Potential 2026 Drug Approval Put $NRXP in a Category of Its Own
By Amy Riolo LLC
In honor of National Nutrition Month, award-winning authors Dr. Simon Poole and Chef Amy Riolo are proud to announce the release of 100 Questions & Answers About Diabetes For Dummies and 100 Questions & Answers About High Blood Pressure for Dummies.
13131874
By CorporateAds
87% Clinical Response From Non-Invasive Neuroplastic Therapy Positions $NRXP at the Forefront of Next-Generation Mental Health Treatment. NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP)
13129791
By CorporateAds
70% Revenue Surge, 437% Gross Profit Explosion, and a Clear Path to the N A S D A Q — Cardiff Lexington Corporation (Stock Symbol: CDIX) $CDIX Is Scaling Fast
13129263
By Century Fasteners Corp.
Century Fasteners Corp. is pleased to announce the appointment of Jayne Williams, a highly experienced sales professional, as an Independent Contractor within the Century Fasteners Sales and Business Development team.
13127938
By CorporateAds
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP: FDA Alignment, 70,000-Patient Real-World Data, and a Debt-Free Balance Sheet Position NRXP for Transformational 2026 Catalysts
13126379
By CorporateAds
$ALEN.U Has a Long-Term Vision and Commitment to Responsible Growth in the Digital Wellness Segment with Dedication to Clarity, Transparency and User-Focused Design
By RADAR PR
WEST END HEALTH has officially opened in Colwyn Bay (Friday), with demand having already exceeded expectations ahead of launch.
13121602
By CorporateAds
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP has Entered into a Joint Offering with neurocare Group for Neuroplastic Therapy Targeting Depression, PTSD and Other Mental Health Afflictions
By PillPaw
New iPhone app makes it easy to set schedules, get reminders, log doses, and keep notes for dogs and cats. Learn more at PillPaw.com and download on the App Store.
By IEI Technology USA Corp.
IEI Technology today announced the HTB-300-MTL-H, a next-generation, medical-grade AI embedded system designed for space-constrained healthcare environments.
13116116
By CorporateAds
First Procedures Performed in Florida by $CDIX Demonstrate Commitment to Best-in-Class Healthcare for Underserved Traumatic Injury Populations
13114497
By CorporateAds
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) NRXP Also Reports Its Superior Preservative-Free IV Ketamine Now Submitted for FDA Abbreviated New Drug Application
13114257
By CorporateAds
NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP; $750 Million Market for Suicidal Depression Market Awaits
By Star Sleep & Wellness
Star Sleep & Wellness, a leading provider of comprehensive sleep disorder care, is proud to announce its expansion into Pearland, Texas at 2501 S Galveston Ave.
By SageTech Medical
A consortium lead by SageTech Medical, a pioneering UK-based company developing sustainable technologies for the healthcare sector, has been awarded £3.6 million in grant funding through Innovate UK's Grand Challenge.

Page: 1 2 NextPage updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share